Difference between revisions of "Part:BBa K3512002"
Gourav saha (Talk | contribs) (Added description) |
|||
| Line 9: | Line 9: | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| + | |||
| + | <span class="mw-headline" id="Usage_and_Biology">Usage and Biology</span> | ||
<!-- --> | <!-- --> | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
| − | <partinfo>BBa_K3512002 SequenceAndFeatures</partinfo> | + | <partinfo>BBa_K3512002 <span class="mw-headline" id="SequenceAndFeatures">Sequence and Features</span></partinfo> |
Revision as of 05:04, 21 October 2020
CcdA Antitoxin
CcdA antitoxin is part of the CcdA-CcdB toxin-antitoxin system. The target of CcdB is the GyrA subunit of DNA gyrase, an essential type II topoisomerase in Escherichia coli. Gyrase alters DNA topology by effecting a transient double-strand break in the DNA backbone, passing the double helix through the gate and resealing the gaps. The CcdB toxin acts by trapping DNA gyrase in a cleaved complex with the gyrase A subunit covalently closed to the cleaved DNA, causing DNA breakage and cell death in a way closely related to quinolones antibiotics.
In absence of the antitoxin CcdA, the CcdB toxin traps DNA-gyrase cleavable complexes, inducing breaks into DNA and cell death.
Sequence and Features BBa_K3512002 Sequence and Features Not understood